Clinical trial
Interventional Left Ventricular Assist System for PCI in CHIP Patients: a Prospective, Multicenter, Noninferiority Randomized Controlled Trial
NCT07053618 is registered in ClinicalTrials.gov with Suzhou Hengruihongyuan Medical Technology Co. LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interventional Left Ventricular Assist System for PCI in CHIP Patients: a Prospective, Multicenter, Noninferiority Randomized Controlled Trial
- Lead sponsor
- Suzhou Hengruihongyuan Medical Technology Co. LTD
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 6, 2025
- Completion date
- August 1, 2027
- Enrollment
- 286 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
high-risk percutaneous coronary intervention (high-risk pci), left ventricular assist devices